Geneos Wealth Management Inc. decreased its stake in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 2.3% ...
Grifols S.A. Cl B 0.94% €5.52B Grifols S.A.-0.02% €5.52B ...
Eris Lifesciences Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the company has reported a ...
SMS Lifesciences India Ltd. key Products/Revenue Segments include Pharmaceuticals, Conversion Charges, Other Operating Revenue and Export Incentives for the year ending 31-Mar-2024.For the quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback